ErminiaMassarelliMD

Hematology • Bradbury, CA

Myeloproliferative Disorder Hematology-Oncology

Physician

Join to view full profile

Dr. Massarelli is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Massarelli's full profile

Already have an account?

Office
1500 Duarte Rd
Bradbury, CA 91010
Phone+1 713-792-6161

Education & Training

University of Texas Health Science Center at Houston/M D Anderson Cancer CenterFellowship, Hematology and Medical Oncology, 2009 - 2013
Methodist Hospital (Houston)Residency, Internal Medicine, 2007 - 2009
University of Naples Faculty of MedicineClass of 1997

Certifications & Licensure

CA State Medical License 2016 - 2025
TX State Medical License 2012 - 2025
American Board of Internal Medicine Medical Oncology

Clinical Trials

BATTLE Program: Erlotinib in Previously Treated Subjects With Advanced NSCLC Start of enrollment: 2006 Nov 01
Completed
Phase 2

Publications & Presentations

PubMed

Clinical Utility of a Circulating Tumor Cell-Based Cerebrospinal Fluid Assay in the Diagnosis and Molecular Analysis of Leptomeningeal Disease in Patients With Advance...
Jyoti Malhotra, Ramya Muddasani, Jeremy Fricke, Isa Mambetsariev, Amanda Reyes
JCO Precision Oncology. 2024-12-01
Cabozantinib Plus Atezolizumab or Cabozantinib Alone in Patients With Advanced NSCLC Previously Treated With an Immune Checkpoint Inhibitor: Results From the Phase 1b ...
Joel W Neal, Armando Santoro, Maria Gonzalez-Cao, Farah Louise Lim, Bruno Fang
JTO Clinical and Research Reports. 2024-10-01
Smoking prevalence and association with sociodemographic variables in cancer clinical trial participants.
Cary A Presant, Cathee Till, Riha Vaidya, Kimlin Tan Ashing, Graham W Warren
Cancer. 2024-09-16

Journal Articles

Combining Immune Checkpoint Blockade and Tumor-Specific Vaccine for Patients with Incurable Human Papillomavirus 16–Related Cancer
Erminia Massarelli, William William, Ming Guo, Merrill Kies, Bonnie Glisson, Hai Tran, Faye Johnson, Renata Ferrarotto, Lei Feng, JAMA

Press Mentions

Business Digest: UT Health Expands Services in TylerSeptember 10th, 2024
City of Hope Now Enrolling Patients for First-in-Human T Cell Trial for HPV-Associated CancersAugust 15th, 2019
Expert Discusses Treatment Advances in ALK-Positive NSCLCJanuary 9th, 2018
Join now to see all